The NATO Innovation Fund has made its first investment in a biotechnology company, co-leading a $35 million fundraising round for Portal Biotech. The UK-based company uses protein sequencing to detect engineered threats and defend against biological warfare. Its AI-backed technology with biological sensors can work at the single molecule level on-site, providing results within hours. Source: Investing.com 30/6/2025